Navigation Links
Watson Confirms EMBEDA(R) Patent Challenge
Date:10/7/2011

PARSIPPANY, N.J., Oct. 7, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Morphine Sulfate and Naltrexone Hydrochloride Extended-release Capsules 30 mg/1.2 mg, 50 mg/2 mg, 60 mg/2.4 mg, 80 mg/3.2 mg, and 100 mg/4 mg.  Watson's Morphine Sulfate and Naltrexone Hydrochloride Capsules are generic versions of EMBEDA® Extended Release Capsules sold by King Pharmaceuticals, Inc., a wholly-owned subsidiary of Pfizer Inc. EMBEDA® is indicated for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Pfizer, King and Alpharma Pharmaceuticals LLC filed suit against Watson on October 6, 2011, in the United States District Court for the District of Delaware seeking to prevent Watson from commercializing its product prior to the expiration of U.S. Patent Nos. 7,682,633; 7,682,634; and 7,815,934.  The lawsuit was filed under the provisions of the Hatch-Waxman Act, resulting in a stay of final FDA approval of Watson's ANDA for up to 30 months from the date the plaintiffs received notice of Watson's ANDA filing or until final resolution of the matter before the court, whichever occurs sooner, subject to any other exclusivities.

Based on available information, Watson believes it may be a "first applicant" to file an ANDA for the generic version of EMBEDA® and, should its ANDA be approved, may be entitled to 180 days of generic market exclusivity.

For the twelve months ending August 31, 2011, EMBEDA® had total U.S. sales of approximately $42 million according to IMS Health data.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is a leadin
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Watson Launches Generic FEMCON(R) Fe
2. Watson to Host Conference Call and Webcast to Discuss Third Quarter 2011 Earnings
3. Watson to Present at the Jefferies 2011 Global Healthcare Conference
4. Watson Confirms Amphastar Patent Lawsuit
5. Watson Pharmaceuticals Announces Approval of Amphastars Generic LOVENOX(R)
6. Watson to Present at the 2011 Bank of America Merrill Lynch Global Healthcare Conference
7. Watson to Present at the 2011 Morgan Stanley Global Healthcare Conference
8. Watsons Anda Distribution to Build 234,000 sq ft Pharmaceutical Warehouse and Distribution Facility in Olive Branch, DeSoto County, MS
9. Watson Enters into Agreement to Acquire Products Related to Perrigos Acquisition of Paddock Laboratories
10. Watson Second Quarter 2011 Net Revenue Exceeds $1 Billion; Non-GAAP EPS of $1.01
11. Watson Confirms JALYN™ Patent Challenge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the ... Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) ... in order to treat dental impairments, for tooth restoration ...
(Date:1/15/2014)... AARP Foundation today announced it has established a ... severe cold weather that has gripped much of the nation. ... need; so to support these emergency relief efforts AARP and ... could mean up to $500,000 in aid. The matching program ...
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: CLSN ) ... investors to purchase an aggregate of approximately $15 million ... direct offering, led by a dedicated health care fund. ... with these investors pursuant to which the Company agreed ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
(Date:7/9/2014)... Vasectomy was associated with a small increased risk of ... lethal prostate cancer according to a new study from ... that the association remained even among men who received ... cancer cannot be explained by diagnostic bias. It is ... look at the link between vasectomy and prostate cancer. ...
(Date:7/9/2014)... of signals active in almost all types of cancer ... and may help fuel a tumour,s uncontrolled growth, new ... Research, London, identified a molecular trigger responsible for ratcheting ... cellular factory that makes the building blocks cancer cells ... TOR signalling pathway, called SREBP, controls the flow of ...
(Date:7/9/2014)... research into the metabolism of stromal support cells and ... of these cell types in the development of diseases ... conditions and cancer. That was the conclusion of a ... in the leading journal Nature . , Prof. ... wake-up call. The metabolism of cancer cells has been ...
(Date:7/9/2014)... drug users in Russia might contribute to HIV ... conducted by researchers from Boston University Schools of ... Petersburg Pavlov State University, sought to discover the ... of a cohort of HIV-positive people with lifetime ... arrested by police were more likely to share ...
(Date:7/9/2014)... news release is available in French . ... factors in 14 year old teens, including brain structure and ... 70% accuracy who will go on to develop binge drinking ... of conscientiousness, and other variables such as life events and ... of binge drinking. Whether or not the child had ...
Breaking Medicine News(10 mins):Health News:Vasectomy may increase risk of aggressive prostate cancer 2Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Wake-up call for more research into cell metabolism 2Health News:BU researchers relate arrests with HIV risk environment 2Health News:What drives a child to abuse alcohol? 2
... Academy of Ophthalmology and the Texas Ophthalmological, Association Remind Parents and ... Eyewear for Youth Sports and Back-to-School ... when an errant paintball smashed into his left eye and sent ... "I remember being very dizzy and I couldn,t stop vomiting," ...
... WASHINGTON, Sept. 1 /PRNewswire-USNewswire/-- Service Employees,International Union (SEIU) ... RN, issued the following statement regarding the work,being ... country in anticipation of,the health impacts of Hurricane ... the Gulf Coast, leaders of the Nurse,Alliance of ...
... Israel, Aug. 31 Elbit Imaging Ltd.,(Nasdaq: EMITF ... for the,second quarter of 2008., Profit for the ... US$ 16.7 million) of which profit of NIS 15.8 ... holders of,the Company and NIS 40.3 million (approximately US$ ...
... WASHINGTON, Aug. 31 As mandatory evacuations are ... is starting to receive,evacuees in shelters throughout the Gulf ... states: Alabama, Mississippi, Louisiana and Texas.,Everyone in the path ... officials,and heed evacuation orders when instructed to do so; ...
... Spanish . , The brain is the ... a complex, orchestrated manner that is related to the activation ... cognitive and emotional processes. It is the brain which finally ... stressful for us, and which regulates the stress responses that ...
... HAMILTON August 31, 2008 -- An international study ... medication used to lower blood pressure, reduced the outcome ... who are unable to tolerate a widely available and ... Teo, professors in the Michael G. DeGroote School of ...
Cached Medicine News:Health News:Keep Eyes Safely On The Ball 2Health News:Keep Eyes Safely On The Ball 3Health News:Nurse Alliance of SEIU Healthcare Mobilizing RNs and Medical Supplies to Gulf Coast Areas in Advance of Hurricane Gustav 2Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 2Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 3Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 4Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 5Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 6Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 7Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 8Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 9Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 10Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 11Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 12Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 13Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 14Health News:American Red Cross Relief Efforts Underway for Gustav 2Health News:Neurogenesis in the adult brain: The association with stress and depression 2Health News:Neurogenesis in the adult brain: The association with stress and depression 3Health News:Neurogenesis in the adult brain: The association with stress and depression 4Health News:Neurogenesis in the adult brain: The association with stress and depression 5Health News:Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke 2
BD Vacutainer Citrate Tubes with 3.2% buffered sodium citrate solution are used for routine coagulation studies....
... Cross-match tubes are available ... serum tube contains a clotting ... cross-match tests where serum is ... EDTA cross-match tube is suitable ...
... tubes are available in two ... contains a clotting activator and ... where serum is required for ... tube is suitable where the ...
Inquire...
Medicine Products: